Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of cannabinoids in the treatment of dyskinesia associated with parkinson's disease

Use of cannabinoids in the treatment of dyskinesia associated with parkinson's disease

US Patent 12350253 · Granted Jul 8, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cannabinoid derivatives as pharmaceutically active compounds and methods of prep2025
Cannabidiol-type cannabinoid compound2025
Cannabidiol-type cannabinoid compound2025
Cannabidiol-type cannabinoid compound2025
Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard ant2025
Use of cannabidiol in the treatment of tuberous sclerosis complex2025
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV2024
Use of cannabinoids in the treatment of a neurodegenerative disease or disorder2024
Use of cannabinoids in the treatment of a neurodegenerative disease or disorder2024
Cannabidiol preparations and its uses2024
7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in th2023
Use of cannabinoids in the treatment of epilepsy2023